NCT06546553 2026-02-23A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.PfizerPhase 1 Terminated10 enrolled
NCT03165721 2026-02-18A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney CancerNational Institutes of Health Clinical Center (CC)Phase 2 Terminated9 enrolled 11 charts
NCT05070247 2026-01-22A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid TumorsTakedaPhase 1/2 Terminated61 enrolled 29 charts
NCT05119335 2025-11-12A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell CarcinomaNiKang Therapeutics, Inc.Phase 1/2 Terminated120 enrolled
NCT04383210 2025-04-03Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid TumorsElevation OncologyPhase 2 Terminated54 enrolled 11 charts
NCT03024437 2025-03-20Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell CarcinomaIndiana UniversityPhase 1/2 Terminated31 enrolled 19 charts